MARKET

ZLAB

ZLAB

Zai Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

54.74
+0.10
+0.18%
After Hours: 54.68 -0.06 -0.11% 16:11 01/24 EST
OPEN
54.64
PREV CLOSE
54.64
HIGH
55.53
LOW
53.69
VOLUME
583.85K
TURNOVER
--
52 WEEK HIGH
55.53
52 WEEK LOW
23.42
MARKET CAP
3.62B
P/E (TTM)
-21.0725
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZLAB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZLAB News

  • The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
  • Benzinga.8h ago
  • Zai Lab prices $261M ADS offering; shares down 2% premarket
  • seekingalpha.1d ago
  • Zai Lab Prices 5.5M ADS Public Offering @$47.50/ADS
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings
  • Benzinga.2d ago

More

Industry

Biotechnology & Medical Research
-2.27%
Pharmaceuticals & Medical Research
-1.88%

Hot Stocks

Name
Price
%Change

About ZLAB

Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
More

Webull offers Zai Lab Ltd (ZLAB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.